US:
UK:
JAPAN:
- Report code : CMI-1876
- Industry : Medical Devices
- Published On : Jun 2018
- Pages : 216 Pages
- Format :
Press Release: Lyophilization/Freeze Drying Equipment Market to Surpass US$ 3.7 Billion by 2026
Press Release: Lyophilization/Freeze Drying Equipment Market to Surpass US$ 3.7 Billion by 2026
Lyophilization/Freeze Drying Equipment Market – Powerful Components of Drug Development & Research
Freeze drying is the removal of ice or other frozen solvents from a material through the process of sublimation and the removal of bound water molecules through the process of desorption. It is an excellent method of preserving a wide variety of heat-sensitive materials such as proteins, microbes, pharmaceuticals, tissues, and plasma. Lyophilization is also used in the biotechnology and biomedical industries to preserve vaccines, blood samples, purified proteins, and other biological material. This process provides an efficient technique for preservation of temperature sensitive and biologic products such as proteins, enzymes, blood plasma, and vaccines.
The global lyophilization/freeze drying equipment market size was valued at US$ 2,116.5 million in 2017, and is expected to exhibit a robust CAGR of 6.5% over the forecast period (2018 – 2026).
Figure 1. Global Lyophilization/Freeze Drying Equipment Market Value (US$ Mn), by Region, 2017
Source: Coherent Market Insights Analysis (2018)
xIncreasing biopharmaceutical production with extensive R&D is expected to drive growth of the market
Increasing number of drug development process and biopharmaceutical research is a major factor augmenting growth of the market as lyophilization is widely used for pharmaceuticals/ biopharmaceuticals to improve stability, thereby achieve adequate shelf life. Lyophilization or freeze-drying is vital process in developing and manufacturing unstable and sensitive pharmaceuticals, as they aid in introducing new pharmaceutical to market. Biopharmaceuticals are produced by genetically modified organisms and are temperature sensitive complex molecules, which require gentle freeze drying with the lyophilisation process to attain adequate shelf life. According to the survey by Martin Christ GmbH, around 60% of the biopharmaceutical products, such as special cancer treatment substances and antibodies, require freeze drying for attaining efficient results in clinical trials. Also, increasing number of global biopharmaceutical companies is expected to boost market growth over the forecast period as these companies are highly dependent on lyophilization due to wide availability of biologics, which include vaccines, blood components, somatic cells, gene therapy, tissues, and recombinant therapeutic proteins. According to Pharmaceutical Research and Manufacturers of America (PhRMA), 2016, biopharmaceutical companies are focused on developing drugs for treatment of diseases such as cancers which has 1,919 medicines in development, 563 medicines for cardiovascular diseases and 1,123 medicines for immunological disorders, which require recombinant proteins for various stages for drug development. Also, according to Pharmaceutical Research and Manufacturers of America (PhRMA), 2016, member companies invested an estimated US$ 58.8 billion in research and development in 2015, which was the majority of all biopharmaceutical R&D spending in the U.S.
Moreover, according to the survey by Future Science Group, 2016, injectable products are majorly selected as formulations for new therapeutics. However, liquid formulations often enhances degradation through hydrolysis. Thus, lyophilization/ freeze-drying is regularly used in pharmaceutical manufacture to reduce water activity and assure product stability.
Increasing funds and high investment for development of drugs to accelerate market growth in Asia Pacific
The lab-scale freeze dryers are used in R&D prior to a scale up, as moving a new product to commercial-scale manufacturing requires careful validation. Demonstrating batch uniformity is an essential part of this critical process. Moreover, freeze-drying has created novel opportunities in the area of oral drug delivery, where the properties of the drugs, excipients and characteristics of the final solid dosage form can be modified by the freeze-drying process. Asia Pacific region is estimated to witness significant growth in the market, owing to increasing number of research laboratories and pharmaceutical companies with increased expenditure on research and development in this region. For instance, according to the National Bureau of Statistics, February 2018, China’s expenditure on research and development increased by 11.6% in 2017 from 10.6% in 2016 reaching to US$ 280 Bn in 2017. According to the International Journal of Sciences, January 2018, China’s biotechnology sector is expected to exceed by 4% of gross domestic product by 2020, and is expected to develop around 10-20 life-science parks for biomedicine with an output surpassing US$ 1.5 billion.
Major players operating in the global lyophilization/freeze drying equipment market include Thermo Fisher Scientific, Inc., Millrock Technology Inc., Zirbus Technology GmbH, SP Scientific, Azbil Telstar, S.L., Biopharma Process Systems Ltd., LTE Scientific Ltd., Martin Christ GmbH, GEA Group, and Cuddon Freeze Dry.
Freeze-drying/lyophilization is typically used in the pharmaceutical companies to recover an active pharmaceutical ingredient from an aqueous solution. The main advantage of freeze drying is that the thermo labile components such as hormones, proteins, hormones can be preserved without damaging the molecules, as they are highly sensitive to heat. The freeze drying products offer a variety of applications in the field of research and development, therapeutic production, medical diagnostics, thus proving to be a beneficial tool in the pharma and biotech industries. The method is highly preferred due to good physical and chemical properties, enhancement in shelf-life of biotechnological products, nutraceuticals, and medicinal products.
Market Dynamics
Increasing demand for freeze dryers/ lyophilization in the pharmaceutical and biotechnology industry, owing to the increasing number of vaccines, recombinant and injectable formulations is a major factor augmenting the market growth as these molecules must be freeze-dried for clinical and commercial use. Also, growth in contract manufacturing and contract lyophilization activities by the manufacturers for pharmaceutical industry is expected to propel the growth of market during the forecast period. Furthermore, the launch of innovative systems offering PLC and PAT based control systems, automated loading, and unloading systems are also expected to contribute to the growth of the market. For instance, in 2012, Azbil Telstar, S.L., launched Telstar Lyotris freeze dryer, designed particularly for aseptic, small-scale production of vaccines, antibodies and other advanced drugs and therapies, which require stabilization. Moreover, the dryer has industrial equipment specifications and small-batch flexibility in a compact envelope. However, increased handling and processing time, cost and complexity of the equipment’s, and removal of volatile components from the vacuum are the factors hindering the market growth.
Key features of the study:
Detailed Segmentation:
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
*Browse 48 market data tables and 36 figures on "Lyophilization/Freeze Drying Equipment Market - Global forecast to 2026”.
Asia Pacific Intelligence Center (India): 